+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Dermatomyositis Associated with Membranous Nephropathy in a 43-Year-Old Female

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          A 43-year-old woman was admitted to our hospital for myalgic pain and erythema of the face and thighs. She had been diagnosed with dermatomyositis at another hospital 8 years earlier and proteinuria had developed suddenly. Renal histological examination revealed membranous nephropathy. Membranous nephropathy associated with dermatomyositis is very rare. To date, malignant disease has not been detected in our patient, but the serum level of CA125, a tumor marker, has been elevated to 1,097 U/ml. The increased CA125 level is related to the degree of proteinuria and after prednisolone and cyclosporine therapy, proteinuria and the CA125 level gradually decreased.

          Related collections

          Most cited references 2

          • Record: found
          • Abstract: not found
          • Article: not found

          Dermatomyositis as a presenting symptom of ovarian cancer

            • Record: found
            • Abstract: not found
            • Article: not found

            Markedly Elevated CA125 in Hepatic Cirrhosis


              Author and article information

              Am J Nephrol
              American Journal of Nephrology
              S. Karger AG
              August 2002
              02 August 2002
              : 22
              : 4
              : 385-388
              aDepartment of Internal Medicine, Kinashi Ohbayashi Hospital and bMiyake Clinic, Takamatu, Kagawa, Japan
              65233 Am J Nephrol 2002;22:385–388
              © 2002 S. Karger AG, Basel

              Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

              Page count
              Figures: 2, Tables: 1, References: 14, Pages: 4
              Self URI (application/pdf): https://www.karger.com/Article/Pdf/65233
              Case Report

              Cardiovascular Medicine, Nephrology

              Membranous nephropathy, CA125, Dermatomyositis


              Comment on this article